ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test (25/box) EXPIRY: 12/31/2025
$325.00
ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid protein antigen from SARS-CoV-2, influenza A and influenza B directly from anterior nasal or nasopharyngeal swab specimens collected from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five (5) days of onset of symptoms, when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.
For custom bulk orders, pricing inquiries, or product dating and pricing please contact orders@dbdiagnostics.com.
EFFICIENT: 3 results to aid in a differential diagnosis at the point of care
RAPID: actionable results in 15 minutes to help improve patient management decisions
HIGHLY CORRELATED TO PCR:1
COVID-19: Sensitivity (Anterior nasal swab) 93.8%; Specificity 100%
COVID-19: Sensitivity (Nasopharyngeal) 93.1%; Specificity 100%
Flu A: Sensitivity 92.2%; Specificity 94.2%
Flu B: Sensitivity 90.0%; Specificity 94.3%
INSTRUMENT-FREE: user-friendly test procedure for non-lab settings
